Case Study: Fimea improves adverse reaction reporting with Solita’s AI solution

Fimea saves significant time on adverse reaction reporting with Solita

The Finnish Medicines Agency Fimea needed to streamline its processing of adverse drug reaction reports. Solita developed an AI solution to assist Fimea's authorities by reducing the time spent on manual information searches, thereby improving reporting quality and supporting decision-making.

Solita implemented an AI application using Retrieval Augmented Generation (RAG) technology and Amazon Bedrock with the Claude model. This solution performs intelligent searches across multiple databases to support assessors, saving a significant amount of time and leading to more consistent reporting. The successful implementation is now a permanent part of Fimea's production environment, enhancing both national and international drug safety.

Fimea